Nifty

:

24273.80

Sensex

:

80334.81

-140.60 (-0.58%)
-411.97 (-0.51%)

Login

Nifty
Sensex

:
:

24273.80
80334.81

-140.60 (-0.58%)
-411.97 (-0.51%)

Alembic Ltd.

Pharmaceuticals & Drugs - API

Rating :

N/A

BSE: 506235 | NSE: ALEMBICLTD

Watchlist

NSE BSE

116.36

06-Feb-2025

Open
High
Low
Previous Close

115.10
118.87
114.81
113.21

Volume
Traded Value (lacs)
52 Week High
52 Week Low

284669
330.84
169.00
85.30

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,519.03
8.01
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,531.90
2.45%
1.11

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

0.90
16.33
26.27

EBITDA CAGR (%)

10 Years
5 Years
3 Years

20.79
78.48
32.49

PAT CAGR (%)

10 Years
5 Years
3 Years

14.42
-0.03
2.52

P:E (Median)

8 Years
5 Years
3 Years

7.98
9.18
10.44

P:BV (Average)

8 Years
5 Years
3 Years

1.18
1.19
1.09

EV:EBITDA (Average)

8 Years
5 Years
3 Years

32.15
34.75
20.98

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 3.62
P/E Ratio 35.79
Revenue 144
EBITDA 56
Net Income 93
ROA 9.8
P/B Ratio 4.11
ROE 11.34
FCFF 13.23
FCFF Yield 0.4

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 55.97 37.94 47.52% 51.10 31.15 64.04% 49.08 35.65 37.67% 47.51 36.10 31.61%
Expenses 30.25 24.80 21.98% 32.72 21.52 52.04% 29.63 25.54 16.01% 24.14 23.32 3.52%
EBITDA 25.72 13.14 95.74% 18.38 9.63 90.86% 19.45 10.11 92.38% 23.37 12.78 82.86%
EBIDTM 45.95% 34.63% 35.97% 30.91% 39.63% 28.36% 49.19% 35.40%
Other Income 4.24 2.21 91.86% 65.59 47.86 37.05% 1.89 2.59 -27.03% 1.95 1.97 -1.02%
Interest 0.52 0.26 100.00% 0.51 0.05 920.00% 0.34 0.05 580.00% 0.33 0.04 725.00%
Depreciation 2.59 2.57 0.78% 2.59 1.77 46.33% 2.41 1.74 38.51% 1.38 1.61 -14.29%
PBT 26.85 12.52 114.46% 80.87 55.67 45.27% 18.59 10.91 70.39% 23.61 2.49 848.19%
Tax 1.16 1.23 -5.69% 4.27 4.24 0.71% 1.75 1.43 22.38% 2.93 -1.80 -
PAT 25.69 11.29 127.55% 76.60 51.43 48.94% 16.84 9.48 77.64% 20.68 4.29 382.05%
PATM 45.90% 29.76% 149.90% 165.10% 34.31% 26.59% 43.53% 11.88%
EPS 1.00 0.44 127.27% 2.98 2.00 49.00% 0.66 0.37 78.38% 0.81 0.17 376.47%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 57.92 39.32 47.30% 52.91 32.28 63.91% 50.78 36.84 37.84% 49.04 37.12 32.11%
Expenses 31.52 27.64 14.04% 33.34 22.13 50.66% 30.38 25.97 16.98% 24.89 23.67 5.15%
EBITDA 26.40 11.68 126.03% 19.57 10.15 92.81% 20.40 10.87 87.67% 24.15 13.45 79.55%
EBIDTM 45.58% 29.70% 36.99% 31.44% 40.17% 29.51% 49.25% 36.23%
Other Income 4.37 2.23 95.96% 65.61 47.87 37.06% 1.96 2.63 -25.48% 2.04 2.03 0.49%
Interest 0.69 0.37 86.49% 0.67 0.13 415.38% 0.49 0.13 276.92% 0.48 0.13 269.23%
Depreciation 2.69 2.66 1.13% 2.68 1.86 44.09% 2.50 1.83 36.61% 1.48 1.70 -12.94%
PBT 27.39 10.88 151.75% 81.83 56.03 46.05% 19.37 11.54 67.85% 24.23 3.04 697.04%
Tax 1.30 0.96 35.42% 4.52 4.32 4.63% 1.95 1.58 23.42% 2.94 -1.66 -
PAT 26.09 9.92 163.00% 77.31 51.71 49.51% 17.42 9.96 74.90% 21.29 4.70 352.98%
PATM 45.04% 25.23% 146.12% 160.19% 34.30% 27.04% 43.41% 12.66%
EPS 2.55 2.39 6.69% 4.71 3.53 33.43% 2.17 1.73 25.43% 2.81 1.88 49.47%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 203.66 152.25 123.16 75.97 72.30 73.69 123.81 125.30 147.16 127.53 143.95 Net Sales Growth 44.60% 23.62% 62.12% 5.08% -1.89% -40.48% -1.19% -14.85% 15.39% -11.41% Cost Of Goods Sold 25.50 48.95 41.12 22.62 22.24 31.71 66.95 78.50 96.33 69.67 74.09 Gross Profit 178.16 103.30 82.04 53.35 50.06 41.98 56.86 46.79 50.83 57.86 69.86 GP Margin 87.48% 67.85% 66.61% 70.23% 69.24% 56.97% 45.93% 37.34% 34.54% 45.37% 48.53% Total Expenditure 116.74 96.00 85.15 63.06 62.21 70.11 106.43 114.21 140.45 121.53 135.35 Power & Fuel Cost - 0.31 1.96 0.05 0.22 0.27 2.34 1.11 5.46 13.26 13.30 % Of Sales - 0.20% 1.59% 0.07% 0.30% 0.37% 1.89% 0.89% 3.71% 10.40% 9.24% Employee Cost - 23.03 24.04 21.47 22.60 20.79 20.52 19.64 22.83 23.79 27.00 % Of Sales - 15.13% 19.52% 28.26% 31.26% 28.21% 16.57% 15.67% 15.51% 18.65% 18.76% Manufacturing Exp. - 9.11 5.98 7.95 5.67 5.99 7.11 6.08 7.11 5.77 11.90 % Of Sales - 5.98% 4.86% 10.46% 7.84% 8.13% 5.74% 4.85% 4.83% 4.52% 8.27% General & Admin Exp. - 10.96 8.81 8.60 6.36 8.26 7.12 6.79 6.48 5.30 4.66 % Of Sales - 7.20% 7.15% 11.32% 8.80% 11.21% 5.75% 5.42% 4.40% 4.16% 3.24% Selling & Distn. Exp. - 1.79 1.74 0.69 0.88 0.87 0.11 0.34 0.90 2.11 2.88 % Of Sales - 1.18% 1.41% 0.91% 1.22% 1.18% 0.09% 0.27% 0.61% 1.65% 2.00% Miscellaneous Exp. - 1.85 1.51 1.67 4.25 2.22 2.28 1.75 1.33 1.64 2.88 % Of Sales - 1.22% 1.23% 2.20% 5.88% 3.01% 1.84% 1.40% 0.90% 1.29% 1.05% EBITDA 86.92 56.25 38.01 12.91 10.09 3.58 17.38 11.09 6.71 6.00 8.60 EBITDA Margin 42.68% 36.95% 30.86% 16.99% 13.96% 4.86% 14.04% 8.85% 4.56% 4.70% 5.97% Other Income 73.67 54.62 64.11 89.09 10.61 93.61 30.16 37.04 30.97 28.81 21.73 Interest 1.70 0.69 0.16 0.23 0.27 0.28 0.22 0.17 0.16 0.12 0.83 Depreciation 8.97 7.46 6.36 4.50 3.91 3.23 2.63 3.78 5.09 6.14 6.04 PBT 149.92 102.72 95.60 97.28 16.52 93.68 44.70 44.17 32.44 28.55 23.46 Tax 10.11 9.83 5.73 11.56 3.15 0.13 3.59 2.39 -0.86 0.61 -0.69 Tax Rate 6.74% 9.57% 6.74% 11.88% 19.07% 0.14% 8.03% 5.41% -3.23% 2.41% -2.94% PAT 139.81 92.89 79.27 85.71 13.36 93.55 41.11 41.78 27.49 24.72 24.15 PAT before Minority Interest 139.81 92.89 79.27 85.71 13.36 93.55 41.11 41.78 27.49 24.72 24.15 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 68.65% 61.01% 64.36% 112.82% 18.48% 126.95% 33.20% 33.34% 18.68% 19.38% 16.78% PAT Growth 82.78% 17.18% -7.51% 541.54% -85.72% 127.56% -1.60% 51.98% 11.21% 2.36% EPS 5.44 3.62 3.09 3.34 0.52 3.64 1.60 1.63 1.07 0.96 0.94

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 210.65 157.49 127.24 78.22 73.52 73.93 123.81 125.30 147.16 127.53 143.95 Net Sales Growth 44.72% 23.77% 62.67% 6.39% -0.55% -40.29% -1.19% -14.85% 15.39% -11.41% Cost Of Goods Sold 25.50 48.95 41.12 22.62 22.24 12.17 54.07 78.50 96.33 69.67 74.09 Gross Profit 185.15 108.53 86.13 55.60 51.28 61.75 69.74 46.79 50.83 57.86 69.86 GP Margin 87.89% 68.91% 67.69% 71.08% 69.75% 83.52% 56.33% 37.34% 34.54% 45.37% 48.53% Total Expenditure 120.13 100.62 86.91 64.29 63.09 70.79 105.74 114.22 140.45 121.53 135.35 Power & Fuel Cost - 1.18 2.02 0.15 0.42 0.91 2.34 1.11 5.46 13.26 13.30 % Of Sales - 0.75% 1.59% 0.19% 0.57% 1.23% 1.89% 0.89% 3.71% 10.40% 9.24% Employee Cost - 23.03 24.04 21.47 22.60 20.79 20.52 19.64 22.83 23.79 27.00 % Of Sales - 14.62% 18.89% 27.45% 30.74% 28.12% 16.57% 15.67% 15.51% 18.65% 18.76% Manufacturing Exp. - 10.92 7.02 8.30 5.91 25.52 20.00 6.08 7.11 5.77 11.90 % Of Sales - 6.93% 5.52% 10.61% 8.04% 34.52% 16.15% 4.85% 4.83% 4.52% 8.27% General & Admin Exp. - 11.85 8.90 9.12 6.63 8.30 7.15 6.80 6.48 5.30 4.66 % Of Sales - 7.52% 6.99% 11.66% 9.02% 11.23% 5.77% 5.43% 4.40% 4.16% 3.24% Selling & Distn. Exp. - 2.19 1.90 0.69 0.92 0.87 0.11 0.34 0.90 2.11 2.88 % Of Sales - 1.39% 1.49% 0.88% 1.25% 1.18% 0.09% 0.27% 0.61% 1.65% 2.00% Miscellaneous Exp. - 2.50 1.90 1.93 4.37 2.23 1.56 1.75 1.33 1.64 2.88 % Of Sales - 1.59% 1.49% 2.47% 5.94% 3.02% 1.26% 1.40% 0.90% 1.29% 1.05% EBITDA 90.52 56.87 40.33 13.93 10.43 3.14 18.07 11.08 6.71 6.00 8.60 EBITDA Margin 42.97% 36.11% 31.70% 17.81% 14.19% 4.25% 14.59% 8.84% 4.56% 4.70% 5.97% Other Income 73.98 54.77 64.26 89.18 10.92 93.54 29.45 37.04 30.97 28.81 21.73 Interest 2.33 1.11 0.47 0.39 0.36 0.29 0.22 0.17 0.16 0.12 0.83 Depreciation 9.35 7.84 6.72 4.86 3.94 3.23 2.63 3.78 5.09 6.14 6.04 PBT 152.82 102.69 97.41 97.86 17.04 93.17 44.67 44.18 32.44 28.55 23.46 Tax 10.71 9.82 6.18 11.66 3.20 0.13 3.59 2.39 -0.86 0.61 -0.69 Tax Rate 7.01% 9.56% 7.12% 11.91% 18.78% 0.14% 8.04% 5.41% -3.23% 2.41% -2.94% PAT 142.11 92.87 80.62 86.19 13.84 93.03 41.08 41.78 27.49 24.72 24.15 PAT before Minority Interest 142.11 92.87 80.62 86.19 13.84 93.03 41.08 41.78 27.49 24.72 24.15 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 67.46% 58.97% 63.36% 110.19% 18.82% 125.84% 33.18% 33.34% 18.68% 19.38% 16.78% PAT Growth 86.28% 15.19% -6.46% 522.76% -85.12% 126.46% -1.68% 51.98% 11.21% 2.36% EPS 5.53 3.62 3.14 3.36 0.54 3.62 1.60 1.63 1.07 0.96 0.94

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 808.76 828.99 1,013.85 826.82 483.10 412.42 448.69 367.72 348.34 264.23 Share Capital 51.36 51.36 51.36 51.36 51.36 51.36 53.41 53.41 53.41 53.41 Total Reserves 757.40 777.63 962.49 775.46 431.74 361.06 395.28 314.31 294.93 210.82 Non-Current Liabilities 47.93 38.12 63.45 51.24 5.87 8.52 14.15 12.61 14.69 38.03 Secured Loans 7.39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.91 1.21 1.10 0.83 0.70 0.72 0.80 0.78 0.64 1.57 Current Liabilities 94.71 86.95 66.89 58.39 45.30 48.80 59.12 68.34 57.68 81.80 Trade Payables 30.41 17.20 19.12 17.34 12.99 24.75 16.42 14.76 16.36 19.19 Other Current Liabilities 31.24 42.46 34.18 30.11 21.58 8.07 31.82 39.20 27.37 26.22 Short Term Borrowings 0.00 0.00 0.00 0.28 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 33.06 27.30 13.59 10.66 10.74 15.97 10.89 14.38 13.95 36.39 Total Liabilities 951.40 954.06 1,144.19 936.45 534.27 469.74 521.96 448.67 420.71 384.06 Net Block 130.54 131.83 133.50 229.70 209.41 186.83 147.41 147.60 146.42 169.02 Gross Block 151.49 151.16 151.16 252.35 228.19 202.40 160.32 158.33 371.75 402.34 Accumulated Depreciation 20.95 19.33 17.66 22.64 18.78 15.57 12.92 10.73 225.34 233.33 Non Current Assets 812.35 780.99 1,003.96 836.84 371.69 370.97 335.25 257.39 251.49 194.65 Capital Work in Progress 1.10 0.13 0.19 37.27 18.69 22.26 31.64 0.16 0.00 2.47 Non Current Investment 399.78 461.07 702.38 565.50 143.58 161.82 155.96 107.57 103.83 22.94 Long Term Loans & Adv. 35.00 0.00 4.98 0.85 0.00 0.05 0.25 2.05 1.25 0.23 Other Non Current Assets 10.64 1.64 2.67 3.52 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 139.05 173.07 140.23 99.62 162.59 98.77 186.71 191.28 169.21 189.41 Current Investments 10.86 41.60 23.59 15.68 53.71 43.46 119.85 104.76 46.13 12.23 Inventories 92.60 88.61 86.87 54.28 35.41 35.33 32.41 50.61 74.90 84.31 Sundry Debtors 17.40 22.68 14.90 13.10 8.89 13.51 25.29 21.60 27.98 48.04 Cash & Bank 2.19 1.79 1.59 6.46 57.86 1.99 0.81 2.32 2.34 2.64 Other Current Assets 16.00 8.92 3.84 2.07 6.72 4.49 8.35 11.98 17.87 42.19 Short Term Loans & Adv. 12.12 9.47 9.43 8.03 5.31 2.59 6.34 9.88 16.24 42.19 Net Current Assets 44.34 86.12 73.34 41.23 117.28 49.97 127.58 122.94 111.53 107.61 Total Assets 951.40 954.06 1,144.19 936.46 534.28 469.74 521.96 448.67 420.70 384.06

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 2,185.56 2,078.03 2,496.58 2,297.03 1,418.04 1,208.53 1,085.77 911.43 803.13 527.81 Share Capital 51.36 51.36 51.36 51.36 51.36 51.36 53.41 53.41 53.41 53.41 Total Reserves 2,134.21 2,026.68 2,445.23 2,245.67 1,366.69 1,157.17 1,032.37 858.02 749.72 474.40 Non-Current Liabilities 52.89 42.74 67.60 52.52 6.88 8.52 14.15 12.61 14.69 38.03 Secured Loans 7.39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.91 1.21 1.10 0.83 0.70 0.72 0.80 0.78 0.64 1.57 Current Liabilities 96.11 89.56 67.76 59.41 45.80 48.80 59.12 68.34 57.68 81.80 Trade Payables 31.02 17.38 19.27 17.81 12.99 24.75 16.42 14.76 16.36 19.19 Other Current Liabilities 33.09 45.05 35.54 30.67 22.07 8.07 31.82 39.20 27.37 26.22 Short Term Borrowings 0.00 0.00 0.00 0.28 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 31.99 27.13 12.96 10.66 10.74 15.97 10.89 14.38 13.95 36.39 Total Liabilities 2,334.56 2,210.33 2,631.94 2,408.96 1,470.72 1,265.85 1,159.04 992.38 875.50 647.64 Net Block 130.59 131.88 133.55 233.55 209.47 186.88 147.46 147.60 146.42 169.02 Gross Block 151.54 151.21 151.21 256.22 228.24 202.45 160.37 158.33 371.75 402.34 Accumulated Depreciation 20.95 19.33 17.66 22.67 18.78 15.57 12.92 10.73 225.34 233.33 Non Current Assets 2,191.38 2,032.45 2,488.63 2,306.87 1,307.90 1,167.08 972.32 801.10 706.29 458.23 Capital Work in Progress 1.10 0.13 0.19 37.27 18.69 22.26 31.64 0.16 0.00 2.47 Non Current Investment 1,774.65 1,708.16 2,182.01 2,030.58 1,078.88 957.76 792.85 651.28 558.62 286.52 Long Term Loans & Adv. 36.22 1.22 6.54 1.95 0.86 0.17 0.38 2.05 1.25 0.23 Other Non Current Assets 10.64 1.64 2.67 3.52 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 143.19 177.89 143.32 102.09 162.82 98.77 186.73 191.28 169.21 189.41 Current Investments 11.34 45.40 25.84 16.59 53.71 43.46 119.85 104.76 46.13 12.23 Inventories 92.60 88.61 86.87 54.28 35.41 35.33 32.41 50.61 74.90 84.31 Sundry Debtors 19.76 23.45 15.22 13.81 8.98 13.51 25.29 21.60 27.98 48.04 Cash & Bank 2.47 1.90 1.85 6.57 58.85 2.01 0.84 2.32 2.34 2.64 Other Current Assets 17.02 8.95 3.89 2.11 5.86 4.47 8.35 11.98 17.87 42.19 Short Term Loans & Adv. 13.10 9.57 9.65 8.73 4.38 2.59 6.34 9.88 16.24 42.19 Net Current Assets 47.08 88.32 75.56 42.68 117.03 49.97 127.61 122.94 111.53 107.61 Total Assets 2,334.57 2,210.34 2,631.95 2,408.96 1,470.72 1,265.85 1,159.05 992.38 875.50 647.64

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 25.33 34.70 -21.87 -1.12 5.48 21.52 23.71 51.63 9.65 21.96 PBT 102.72 85.00 97.28 16.52 93.68 44.70 44.17 26.63 25.33 23.46 Adjustment -42.82 -53.46 -79.16 1.54 -85.77 -20.50 -28.84 -20.86 -16.51 -12.43 Changes in Working Capital -36.22 9.59 -31.35 -17.22 -0.94 1.97 12.02 46.06 1.70 10.12 Cash after chg. in Working capital 23.68 41.13 -13.23 0.84 6.97 26.16 27.35 51.83 10.52 21.15 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 1.65 -6.43 -8.64 -1.95 -1.49 -4.64 -3.64 -0.20 -0.87 0.81 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 22.60 11.29 22.66 -35.15 56.79 71.66 -22.55 -46.69 -4.76 4.68 Net Fixed Assets -1.30 0.06 138.27 -42.74 -22.22 -32.70 -33.47 213.26 33.06 -0.08 Net Investments 92.03 223.30 -144.79 -383.89 7.99 70.53 -63.48 -62.37 -114.79 -13.76 Others -68.13 -212.07 29.18 391.48 71.02 33.83 74.40 -197.58 76.97 18.52 Cash from Financing Activity -47.77 -46.08 -5.66 -15.27 -6.40 -92.01 -2.66 -4.96 -5.19 -24.95 Net Cash Inflow / Outflow 0.16 -0.09 -4.86 -51.53 55.87 1.17 -1.50 -0.02 -0.30 1.68 Opening Cash & Equivalents 0.83 0.92 5.78 57.30 1.99 0.81 2.32 2.34 2.64 0.96 Closing Cash & Equivalent 0.99 0.83 0.92 5.78 57.86 1.99 0.81 2.32 2.34 2.64

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 10
Cash From Operating Activity 22.69 38.85 -17.75 -2.18 6.54 21.51 23.58 51.63 9.65 149.09 PBT 102.69 86.80 97.86 17.04 93.17 44.67 44.18 26.63 25.33 43.81 Adjustment -42.09 -52.87 -78.66 1.65 -85.70 -20.51 -28.85 -20.86 -16.51 73.14 Changes in Working Capital -38.47 11.44 -27.90 -18.64 0.60 1.99 11.89 46.06 1.70 36.16 Cash after chg. in Working capital 22.12 45.37 -8.70 0.05 8.06 26.15 27.22 51.83 10.52 153.11 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.57 -6.52 -9.04 -2.23 -1.53 -4.64 -3.64 -0.20 -0.87 -4.02 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 25.84 7.30 18.85 -34.87 56.72 71.67 -22.40 -46.69 -4.76 -23.50 Net Fixed Assets -1.30 0.06 138.27 -42.74 -22.22 -32.70 -33.47 213.26 344.49 -27.30 Net Investments 92.03 223.30 -144.79 -383.89 7.99 70.53 -63.48 -62.37 -141.47 -0.04 Others -64.89 -216.06 25.37 391.76 70.95 33.84 74.55 -197.58 -207.78 3.84 Cash from Financing Activity -48.19 -46.39 -5.82 -15.36 -6.41 -92.01 -2.66 -4.96 -5.19 -118.15 Net Cash Inflow / Outflow 0.33 -0.24 -4.72 -52.41 56.85 1.17 -1.48 -0.02 -0.30 7.45 Opening Cash & Equivalents 0.93 1.17 5.89 58.30 2.01 0.84 2.32 2.34 2.64 16.41 Closing Cash & Equivalent 1.26 0.93 1.17 5.89 58.85 2.01 0.84 2.32 2.34 23.85

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 31.50 32.28 39.48 32.20 18.81 16.06 16.80 13.77 13.04 9.89 ROA 9.75% 7.56% 8.24% 1.82% 18.64% 8.29% 8.61% 6.32% 6.14% 6.25% ROE 11.34% 8.60% 9.31% 2.04% 20.89% 9.55% 10.23% 7.68% 8.07% 9.76% ROCE 12.56% 9.24% 10.59% 2.56% 20.98% 10.43% 10.86% 7.48% 8.31% 9.41% Fixed Asset Turnover 1.01 0.81 0.50 0.30 0.34 0.68 0.80 0.58 0.35 0.37 Receivable days 48.04 55.69 67.26 55.52 55.48 57.19 67.34 59.14 103.47 92.33 Inventory Days 217.22 260.04 339.07 226.41 175.20 99.84 119.22 149.70 216.71 230.21 Payable days 177.48 161.20 294.16 248.85 121.82 74.61 55.73 40.49 60.75 83.96 Cash Conversion Cycle 87.78 154.53 112.18 33.08 108.86 82.42 130.83 168.35 259.43 238.58 Total Debt/Equity 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 150.47 545.84 423.58 63.01 337.75 207.74 261.77 169.23 221.26 29.30

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 85.11 80.93 97.23 89.45 55.22 47.06 40.66 34.13 30.08 19.77 ROA 4.09% 3.33% 3.42% 0.71% 6.80% 3.39% 3.88% 2.94% 3.25% 2.88% ROE 4.36% 3.52% 3.60% 0.75% 7.08% 3.58% 4.18% 3.21% 3.71% 5.58% ROCE 4.86% 3.82% 4.10% 0.94% 7.12% 3.91% 4.44% 3.12% 3.82% 3.82% Fixed Asset Turnover 1.04 0.84 0.52 0.30 0.34 0.68 0.80 0.58 0.35 0.27 Receivable days 50.07 55.47 67.74 56.58 55.52 57.19 67.34 59.14 103.47 293.96 Inventory Days 210.00 251.69 329.34 222.67 174.64 99.84 119.22 149.70 216.71 401.78 Payable days 180.44 162.67 299.17 252.73 120.48 74.61 55.73 40.49 60.75 331.66 Cash Conversion Cycle 79.64 144.48 97.90 26.52 109.68 82.42 130.83 168.35 259.43 364.08 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 93.63 187.54 252.50 48.08 324.49 207.64 261.78 169.23 221.26 29.30

Top Investors:

investor education and protection fund (iepf)

Annual Reports:

News Update:

Alembic - Quarterly Results
7th Feb 2025, 17:50 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback